Anxiety and depression in patients with obstructive sleep apnea before and after treatment with continuous positive airway pressure

IF 0.2 Q4 RESPIRATORY SYSTEM
M. Zamzam, Rabab A. El-Wahsh, A. El-Abedin, Hend Bedir, Asmaa Abdel Tawab
{"title":"Anxiety and depression in patients with obstructive sleep apnea before and after treatment with continuous positive airway pressure","authors":"M. Zamzam, Rabab A. El-Wahsh, A. El-Abedin, Hend Bedir, Asmaa Abdel Tawab","doi":"10.4103/ecdt.ecdt_42_22","DOIUrl":null,"url":null,"abstract":"Aim To evaluate the prevalence of anxiety and depression in patients with obstructive sleep apnea (OSA) and effect of continuous positive airway pressure (CPAP) or weight reduction treatments on anxiety and depression. Background OSA is a life-threatening condition. Poor sleep quality, frequent arousals during sleep, and intermittent hypoxia that accompany patients with OSA could contribute to psychological disturbances. Patients and methods A total of 40 patients with OSA (19 males and 21 females) who were admitted to the Chest Department of Menoufia University Hospitals were included and divided into two groups based on different treatment: 20 patients were treated with CPAP and 20 patients were treated with weight reduction. Results There were no significant differences between both groups regarding age, sex, and BMI. The patients in both groups had high scores in Hamilton anxiety rating scale, Hamilton depression scale, and quality-of-life scale. CPAP and weight reduction treatment for 3 months resulted in significant improvements of anxiety and depressive symptoms. The Hamilton anxiety rating scale decreased from 11.7 ± 6.5 to 3.3 ± 1.8 in group 1 and from 9.6 ± 4.4 to 3 ± 2.1 in group 2, whereas the Hamilton depression scale score decreased from 16.5 ± 5.8 to 4.8 ± 2.1 in group 1 and from 17.5 ± 6.4 to 5.7 ± 2.6 in group 2 (both P<0.001). There were significant improvements in the quality of life in the two groups after 3 months of treatment. Conclusion Anxiety and depression are associated with OSA which improved after CPAP and weight reduction treatment.","PeriodicalId":46359,"journal":{"name":"Egyptian Journal of Chest Diseases and Tuberculosis","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Chest Diseases and Tuberculosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ecdt.ecdt_42_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Aim To evaluate the prevalence of anxiety and depression in patients with obstructive sleep apnea (OSA) and effect of continuous positive airway pressure (CPAP) or weight reduction treatments on anxiety and depression. Background OSA is a life-threatening condition. Poor sleep quality, frequent arousals during sleep, and intermittent hypoxia that accompany patients with OSA could contribute to psychological disturbances. Patients and methods A total of 40 patients with OSA (19 males and 21 females) who were admitted to the Chest Department of Menoufia University Hospitals were included and divided into two groups based on different treatment: 20 patients were treated with CPAP and 20 patients were treated with weight reduction. Results There were no significant differences between both groups regarding age, sex, and BMI. The patients in both groups had high scores in Hamilton anxiety rating scale, Hamilton depression scale, and quality-of-life scale. CPAP and weight reduction treatment for 3 months resulted in significant improvements of anxiety and depressive symptoms. The Hamilton anxiety rating scale decreased from 11.7 ± 6.5 to 3.3 ± 1.8 in group 1 and from 9.6 ± 4.4 to 3 ± 2.1 in group 2, whereas the Hamilton depression scale score decreased from 16.5 ± 5.8 to 4.8 ± 2.1 in group 1 and from 17.5 ± 6.4 to 5.7 ± 2.6 in group 2 (both P<0.001). There were significant improvements in the quality of life in the two groups after 3 months of treatment. Conclusion Anxiety and depression are associated with OSA which improved after CPAP and weight reduction treatment.
阻塞性睡眠呼吸暂停患者持续气道正压治疗前后的焦虑和抑郁
目的探讨阻塞性睡眠呼吸暂停(OSA)患者焦虑和抑郁的患病率,以及持续气道正压通气(CPAP)或减肥治疗对焦虑和抑郁的影响。OSA是一种危及生命的疾病。OSA患者睡眠质量差、睡眠中频繁觉醒、间歇性缺氧可导致心理障碍。患者与方法选取Menoufia大学附属医院胸科收治的OSA患者40例(男19例,女21例),根据治疗方法的不同分为两组:CPAP组20例,减肥组20例。结果两组患者在年龄、性别、BMI方面无显著差异。两组患者汉密尔顿焦虑量表、汉密尔顿抑郁量表和生活质量量表得分均较高。CPAP和减肥治疗3个月后,焦虑和抑郁症状明显改善。汉密尔顿焦虑量表由11.7±6.5降至3.3±1.8,由9.6±4.4降至3±2.1,而汉密尔顿抑郁量表由16.5±5.8降至4.8±2.1,由17.5±6.4降至5.7±2.6 (P均<0.001)。治疗3个月后,两组患者的生活质量均有显著改善。结论焦虑、抑郁与OSA相关,经CPAP和减肥治疗后症状有所改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
46
审稿时长
22 weeks
期刊介绍: The journal will cover technical and clinical studies related to health, ethical and social issues in field of The Egyptian Journal of Chest Diseases and Tuberculosis aims to publish and inform readers and all chest physicians of the progress in medical research concerning all aspect of chest diseases. Publications include original articles review articles, editorials, case studies and reports which are relevant to chest diseases. The Journal also aims to highlight recent updates in chest medicine. . Articles with clinical interest and implications will be given preference.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信